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Background:  Lung cancer is one of the most common cancers worldwide and has the highest 
cancer-related mortality rate.  Epidemiologic studies, including the Environment and Genetics in 
Lung Cancer Etiology (EAGLE) study, have reported that frequent consumption of quercetin-
rich foods is inversely associated with lung cancer incidence.  Although experimental studies 
suggest that quercetin intake might modulate microRNA (miR) expression, this mechanism has 
not been fully examined.  We investigated this hypothesis in lung carcinogenesis using EAGLE 
lung cancer tissues.   
Methods:  miR expression data were measured by a custom-made array in formalin-fixed 
paraffin-embedded tissue samples from 264 lung cancer cases (144 adenocarcinomas and 120 
squamous cell carcinomas). Intake of quercetin-rich foods was derived from a food-frequency 
questionnaire.  Individuals were categorized into sex-specific tertiles of quercetin-rich food 
intake.  In individual-miR-based analyses, we compared the expression of miRs (n=198) between 
lung cancer cases consuming high-versus-low quercetin-rich food intake using multivariate 
ANOVA tests.  In family-miR-based analyses, we grouped individual miRs into biologically 
functional families and conducted analyses using Functional Class Scoring (FCS).  We 
accounted for multiple testing using 10,000 global permutations (significance at p-valueglobal 
<0.10).  All analyses were conducted separately by histology (adenocarcinoma and squamous 
cell carcinoma) and by smoking status (former and current smokers).  Results:  Family-based 
analyses showed that a quercetin-rich diet strongly differentiated miR expression profiles of the 
let-7 family among adenocarcinomas (p-valueFCS<0.001).  Other significantly differentiated miR 
families included miR-146, miR-26, and miR-17 (p-valuesFCS<0.05).  In the individual-based 





observed to be differentiated between highest and lowest quercetin-rich consumers (23 expected 
by chance; p-valueglobal = 0.047). Additionally, we identified 25 miRs to be differentially 
expressed among former smokers with adenocarcinoma (22 expected by chance; p-
valueglobal=0.076).  Conclusions:  We observed differential expression of key biologically 
functional miRNAs between high-versus-low consumers of quercetin-rich foods in 
adenocarcinoma cases.  Our findings, the first of this kind, warrant confirmation from larger 
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Quercetin is a polyphenol ubiquitously present in certain fruits (e.g., apples and grapes) 





  and others 
3-5
 previously observed that a quercetin-rich diet 
was associated with lower risk of lung cancer.  Quercetin and quercetin-rich foods may prevent 
carcinogenesis via several mechanisms 
6
, including free radical scavenging, pro-apoptotic and 
anti-proliferation pathway mediation, modification of anti-inflammatory responses,  and 
activation of detoxifying Phase II enzymes 
7-10
.   
New findings suggested that polyphenol compounds like quercetin  are more likely to 
interact with cellular signaling cascades that regulate transcription factors.
11
  More specifically, 
in vitro
12, 13
 and in vivo
14
 studies showed that they modulate a wide range of miR expressions and 
may consequently influence carcinogenesis. 
13, 14
  MiRs are short, non-coding, single-stranded 
RNAs involved in gene expression of multiple target mRNAs.
15
  Misregulated miRs have been 
implicated in many cancers where they act to promote overexpression of oncogenes and 
underexpression of tumor suppressor genes.
16
  For example, the let-7 class of miRs function as 
tumor suppressors by repressing cell proliferation and regulating both RAS and c-myc 
oncogenes.
17
  In lung cancer, we previously showed that the let-7 family is differentially 
expressed by histology and is associated with survival in the Environment And Genetics in Lung 
Cancer Etiology (EAGLE) study.
15
  
 Polyphenolic compounds, including quercetin, have been shown to alter expression of 
several cancer-related miRs, including the cancer-associated let-7 family.
18-23
   Quercetin 
metabolites were observed to modulate miR-155 in murine macrophages
18
 and miR-146a in 
colon cancer cells.
21





16 in human hepatocellular cancer cells.
23
  Additionally, differential expression of the let-7 




The emerging evidence from in vitro and in vivo investigations provides biological 
rationale to examine the influence of quercetin on miR expression in lung carcinogenesis in the 
present epidemiologic study.  As a follow-up study to our observation that a quercetin-rich diet 
was inversely associated with lung cancer in EAGLE participants,
24
 we investigated the 
influence of quercetin-rich food consumption on miR expression signatures in lung tissues of 
lung cancer patients. Given the importance of let-7 in lung carcinogenesis and their association 
with polyphenols, we specifically focused on several members of the let-7 family as a priori 
candidates for quercetin modification.  To our knowledge, this is the first mechanistic 
investigation of this nature using human tissues in relation to dietary quercetin-rich food 
consumption. 
 
Materials and Methods 
Study population 
The present study is based on 144 adenocarcinoma (AD) and 120 squamous cell 
carcinoma (SQ) subjects from the EAGLE case-control study.  The EAGLE study design has 
been previously described.
25
  Briefly, EAGLE is a population-based case-control study of lung 
cancer conducted in the Lombardy region of Italy between 2002 and 2005 
(http://dceg.cancer.gov/eagle). Confirmed, incident, lung cancer cases (N=2100) were recruited 
from 13 hospitals that examined ~80% of all cases within the catchment area, which included 5 





of cases (95%) were confirmed by pathology reports and the remaining cases by imaging and 
documentation of clinical history. Histologic type was recorded for all cases.  
 
miR expression data 
We previously described the miR expression data from EAGLE.
15
  Briefly, the miR 
expression data were derived from formalin-fixed paraffin-embedded (FFPE) tissue samples in 
144 lung adenocarcinoma and 120 squamous cell carcinoma cases from EAGLE. The 264 
individuals included in the current study were a subgroup with both dietary quercetin 
information and miR expression data. The miRs were analyzed using a custom-made, two-
channel oligo-array that included a total of 713 human, mammalian, and viral mature antisense 
miRs standardized to one EBV cell line. Individual miRs with low overall signal intensity (<100) 
or low signal/noise ratio were excluded. Of the 440 human miRs, a total of 198 miRs were 
retained in the final analysis and are reported in Supplemental Table S1.  
 
Epidemiologic and Quercetin-rich food data 
At baseline, epidemiologic data were collected using both a computer-assisted personal 
interview and a self-administered questionnaire to address potential risk factors associated with 
lung cancer, including comprehensive data on smoking exposure and dietary intake specific to 
this Italian population.
25
  Dietary intake in the previous year was obtained from a self-
administered 58 item food frequency questionnaire (FFQ) where frequency of consumption was 
designated using 11 possible response categories that ranged from ‘never’ to ‘2 or more times a 
day’.  Quercetin-rich food items (apples, grapes, onions, artichoke/fennel/celery, beans/chick 





identified based on data published in the United States Department of Agriculture on food-
specific quercetin content (>0.50 mg/100g).
26
  We created a summary measure of quercetin-rich 




 Quercetin-rich food intake was divided into sex-specific tertiles based on the distribution 
of the controls from the EAGLE study.
2
  We further defined highest and lowest consumers of 
quercetin-rich foods to be those in the third and first tertile, respectively.  We previously showed 
that miR levels differed by histology in this population
15
 and miR expression was found to be 
associated with smoking status;
27
  therefore, all our analyses were performed for smoking-
specific (former and current smokers) and lung cancer subtype (adenocarcinoma and squamous 
cell carcinoma).  Although we examined the influence of quercetin-rich food intake on miR 
expression in never smokers, the results were unstable and not reported due to too few 
individuals (n=29).  
 
Individual-miR-based analyses:  We first compared the expression levels of 198 miRs between 
highest (T3) and lowest (T1) quercetin-rich food consumers using multivariate ANOVA tests. 
Models were adjusted for age (continuous), sex, body mass index (continuous), smoking 
intensity (pack-years, continuous), consumption of non-quercetin-rich fruits and vegetables 
(continuous), red/processed meats (continuous), and lifetime alcohol consumption (continuous).  
Selection of covariates was based on factors that have been associated with either miR 
expression or lung cancer risk.  Individual food items comprised within the individual food 





To further address the issue of multiple comparisons we calculated a global p-value 
(pglobal).  For this calculation, we randomly permuted the highest and lowest classes of quercetin 
intake 10,000X where the number of significant miRs from ANOVA testing was recorded (n
P
). 
The global p-value is then defined as one plus the number of times in which n
p
 was at least as 
large as the number of original significant miRs divided by10,000.  
 
Family-miR-based analyses:  We grouped each miR into known biological functional families 
using MiRBase release 17.0 (http://microrna.sanger.ac.uk/).   We first assembled miRs into 
families based on unique ‘seed sequence’ (nucleotides 2-7 at the 5’end) and identified 21 miR 
families (Supplemental Table S3).  We then restricted our analyses to 9 miR families with at 
least one miR identified at a p-value < 0.05 in the individual-miR-based analyses (Table 3).  We 
used Functional Class Scoring (FCS) to compare the expression profile of each miR family 
between high-versus-low consumers of a quercetin-rich diet.   
FCS computes p-values by assigning all miRs within a particular group (or family) an 
aggregate raw score (the arithmetic mean of the negative natural logarithm of each p-value 
obtained from miR analyses).
28
 This raw score was then compared to the score of randomly 
derived groups of the same size through q repeated samplings (q=1,000). Each score was ordered 
in ascending order to build an empirically derived score distribution. The FCS p-value was 
determined as the fraction of randomly sampled groups having a higher score than the group 
score of interest.   For these analyses, we defined statistical significance at a p-valueFCS <0.05.  






Permutations were performed in the statistical package R and we considered a permuted 




In the present study, lung cancer cases had a mean age at diagnosis of 65 years.  Table 1 
presents the distribution of selected characteristics by tertiles of quercetin intake, separately for 
adenocarcinoma and squamous cell carcinoma.  Among ever smokers, highest (T3) consumers of 
quercetin-rich foods smoked less and were more likely to be AD cases compared with low 
consumers.  Former smokers on average consumed more servings of quercetin-rich foods per day 
than current smokers (1.65±0.88 vs. 1.29±0.79).  Compared with AD cases, SQ cases tended to 
be males, smoked more, and consumed more alcohol and meat across tertiles of quercetin intake.  
Never smokers (n=29) were all AD except for one individual.   
 
Individual- miR-based expression 
We identified 16 miRs that were differentially expressed for AD (4 miRs) and SQ (12 
miRs) cases (p-values < 0.05) between high-versus-low consumers of quercetin-rich foods 
(Table 2).  Likewise, 19 miRs were differentially expressed for former (12 miRs) and current (7 
miRs) smokers (see Supplemental Table S4).   
Table 3 presents analyses examining the association of quercetin-rich diet with miR 
expression within histologic subtypes for former and current smokers separately.  We identified 
48 unique miRs that were differentially expressed between highest-vs-lowest quercetin-rich 





decrease tumor metastasis and invasion (miR-146a/b, -503, and  -194), decrease cell proliferation 
(miR-125a, -155, let-7 family, -302c, -195, -26a, -503, and -215), increase apoptosis (miR-125a, 
-605, -26b, let-7g, -34a, -491, and -16), and target tumor suppressors (let-7 family , miR-125a, -
183, -146a, -98, -19b, -106a, and -381).  
Among former and current smokers with AD, 33 miRs were observed to be differentiated 
between highest and lowest quercetin-rich consumers (23 expected by chance; p-valueglobal = 
0.047, Table 3).  For SQ cases, we identified 15 miRs (p-valueglobal > 0.10).   
Quercetin-associated miR expression profiles appeared to be more prevalent among 
former smokers with AD.  In this group, we identified 25 miRs with a p-value < 0.05 (22 
expected by chance; p-valueglobal = 0.076).  The largest fold-change was observed for miR-26b, a 
proapoptotic miR (fold-change = 2.00; p-value = 0.020). Notably, among the identified 
significant miRs, all of the let-7 family members (let-7a, let-7b, let-7c, let-7d, let-7e, let-7f, let-
7g, let-7i, and miR-98) were associated with a quercetin-rich diet at a p-value ≤ 0.05.  Moreover, 
the majority of let-7 family members were up-regulated with increasing frequency of quercetin 
intake (Figure 1).   
In comparison to AD cases, far fewer miRs were identified at a p-value < 0.05 among SQ 
cases.  None of these groups were statistically significant when we calculated the global p-value 
(p-valuesglobal > 0.10). 
 
Family- miR-based expression 
Table 4 presents the results examining the association of quercetin-rich foods with 
families of miRs in smoking-specific analyses for AD and SQ cases. A quercetin-rich diet 





group, our data showed that the let-7 family was strongly differentiated by a quercetin-rich diet 
(p-valueFCS < 0.001, Table 4) followed by miR-146 (p-valueFCS = 0.002), miR-26 (p-valueFCS = 
0.010), and miR-17 (p-valueFCS = 0.031).  Both the let 7 and the miR-146 families remained 
significant after Bonferroni correction for multiple comparisons (0.05/9 = 0.006).  We observed 
no significant difference in miR expression for SQ cases and current smokers regardless of 
histology. 
Figure 1 graphically depicts the directionality of quercetin-associated miR expression of 
let 7, miR-146, miR-26, and miR17 families with a quercetin-rich diet for formers smokers with 
AD.  In general, members of the let-7 family, miR-26 as well as miR-146b were up-regulated.  In 
contrast, the expression of miR-146a was downregulated. 
 
Discussion 
We previously observed higher consumption of quercetin-rich foods to be associated with 
lower risk of lung cancer in a large population-based case-control study in Italy.  The present 
study tests the hypothesis that a quercetin-rich diet modulates the expression of miRs in human 
lung tissues.  In individual-miR-based analyses, we identified significant quercetin-associated 
miR expression signatures for 48 unique miRs among AD and SQ cases who were former or 
current smokers.  The identified miRs have been shown to decrease cellular proliferation, reduce 
tumor metastasis, and increase apoptosis in smoking-specific analyses (see Supplemental, Table 
S5 for specific miRs).   In family-miR-based analyses, we found that the large majority of 
members of the let 7 family were upregulated among former smokers with AD who consumed a 





observed similar family-based results for miR-146, miR-26, and miR-17 families (p-valueFCS < 
0.05) in this group.   
Due to its association with lung cancer, we specifically focused on the let-7 class of miRs 
in relation to a quercetin-rich diet. In addition to being the most statistically significant result 
based on FCS in the family-based analyses, the let-7 family remained significant after Bonferroni 
correction at p-value < 0.006.  Members of the let-7 family are known to function as tumor 
suppressors in lung carcinoma by repressing NSCLC cell proliferation
17, 29
 and by negatively 
regulating the RAS oncogene.
30
   Among the let-7 miRs in the present study, let-7a, a known 
suppressor of k-RAS and c-Myc oncogenes,
31
  exhibited the largest fold change (fold-change = 
1.46). Our data suggest a possible mechanism of quercetin-related tumor protection through the 
increased expression of these key tumor suppressors.    
 We also observed differential quercetin-associated expression of the miR-17 family 
(miR-20a, -20b, -106a, -106b, -17, and -93) in former smokers with AD.  MiR-17 family belongs 
to the oncogenic miR-17-92 cluster.
32
  Investigators have shown that the miR-17-92 cluster is 
frequently overexpressed in lung cancer.
33
  Expression of miR-17 is associated with poorer 
prognosis and cellular proliferation 
34
 while miR-106b targets p21 and subsequently promotes 
cell cycle progression.
35
  Additionally, suppression of miR-20a induces apoptosis in lung 
cancer.
36
  In our study, the majority of the miRs (67%) in miR-17 family were downregulated in 
frequent consumers of quercetin-rich food among former smokers with AD.     
Quercetin-rich food consumption also significantly differentiated miR-146 and miR-26 
families in our study. Neither of these miR families has been extensively studied with respect to 
lung carcinogenesis; however, both families have been associated with tumor development.  In 







 Additionally, miR-146a is one of two known miRs (miR-146a and -155) involved 
in inflammatory signaling pathways and has been observed to be upregulated by quercetin in 
experimental study.
21
   We corroborated this upregulation of miR-146a among higher consumers 
of quercetin in the present study.  One study showed that miR-155, a pro-inflammatory miR, was 
downregulated with quercetin in murine cells.
18
  In lung carcinoma, miR-155 has often been seen 
to be upregulated and to have prognostic impact.
40
 However, it has also been suggested to 
function as a tumor suppressor by repressing cell proliferation.
41
  In the present study, miR-155 
was not significant in the individual-miR-based analyses by histology and smoking status.  
Both miR-26a and miR-26b exhibited the greatest fold change in our individual miR-
based analyses (miR-26a, FC=1.78) and (miR-26b, FC=2.00).  Our data suggest that a quercetin-
rich diet increases the expression of the miR-26 family, which has been shown to suppress cell 
proliferation in nasopharyngeal carcinoma through G1 phase arrest and repression of c-Myc 
38
 as 
well as induce apoptosis in breast cancer cells.
39
 Proapoptotic characteristics of miR-26 make 
this particular group of miRs an important candidate for study in future research investigating 
quercetin-mediated miR-targets. 
We previously identified a miR expression profile that strongly differentiated 
adenocarcinoma from squamous cell carcinoma with prognostic implications in EAGLE.
15
  
Results from this present study showed consumption of quercetin-rich foods is associated with 
differential miR expression by histology.  In general, our data suggest that quercetin-rich foods 
influenced miR expression in former smokers with AD, but not for SQ and current smokers.  The 
modest fold-change effect of dietary quercetin on miR expression might only be detectable in a 
milieu that is less saturated by smoking exposure, as in former smokers and in AD which is less 
associated with smoking than SQ.
42





average smoked less intensely than SQ cases.  The anti-carcinogenic capabilities associated with 
dietary quercetin may be weakened in SQ cases by competing tobacco-related carcinogens. 
 To our knowledge, the present study is the only investigation of the association of dietary 
quercetin with miR expression in lung tissues.  In addition to having both dietary information 
and miR expression data, this study included several variables that allowed tight control for 
potential confounders.  This richness of epidemiologic data coupled with epigenetic data from 
human tissues permitted an integrative approach—making it possible to explore underlying 
mechanisms that may explain the protective effect of quercetin and lung cancer risk.  
Despite its uniqueness, the study had a limited sample size, which reduces statistical 
precision, and explored a limited number of human miRs.   Although the EAGLE questionnaire 
assessed food consumption a year prior to the study, we cannot exclude the possibility that lung 
cancer diagnosis had influenced the patients’ responses. However, this potential recall bias 
should not have differentially affected the adenocarcinoma or squamous cell carcinoma cases 
and could not explain the different association with quercetin by histologic type. Moreover, we 
derived a quercetin-rich diet from food items available in the EAGLE’s FFQ and not measured 
quercetin content directly; thus, we cannot rule out the contribution of other flavonoids or 
nutrients that are found in those foods.  Confirmation in a larger prospective study with both 
dietary quercetin information and miR expression data is warranted.  
 In conclusion, we observed that a quercetin-rich diet is associated with differential 
expression of key miRs in lung tissue within smoking specific histology groups. Notably, 
expression of miRs in the let-7 family, a known tumor suppressor, was strongly associated with 












T1 (n=57) T2 (n=47) T3 (n=40) p -value T1 (n=48) T2 (n=42) T3 (n=30) p -value
0.79 (0.42) 1.56 (0.46) 2.45 (0.53) 0.71 (0.37) 1.47 (0.44) 2.53 (0.67)
62.58 + 9.03 64.58 + 8.21 65.57 + 8.55 0.22
c 68.48 + 7.09 69.02 + 6.30 66.37+ 8.62 0.29
c
38 (66.67) 25 (53.19) 20 (50.0) 0.20
d 46 (95.83) 42 (100) 30 (100) 0.22
d
24.42 + 3.76 25.59 + 3.98 24.42 + 3.17 0.21






4 (7.02) 16 (34.04) 7 (17.50) 0 1 (2.38) 0
22 (38.60) 12 (25.53) 22 (55.0) 18 (37.50) 20 (47.62) 20 (66.67)
31 (54.39) 19 (40.43) 11 (27.50) 30 (62.50) 21 (50.0) 10 (33.33)
40.0 (24.0) 34.5 (32.0) 33.0 (28.0) 0.63
e 54.0 (28.25) 46.25 (21.70) 42.50 (33.0) 0.22
e
Intake 
1.01 (0.43) 2.03 (0.79) 2.46 (1.93) <0.01
e 0.95 (0.51) 1.68 (0.94) 2.61 (1.83) <0.01
e
0.96 (0.82) 1.78 (1.28) 2.80 (1.40) <0.01
e 1.03 (0.89) 1.55 (0.69) 3.00 (1.37) <0.01
e
0.70 (0.68) 1.07 (0.79) 0.94 (0.98) 0.01
e 1.07 (0.94) 1.23 (1.27) 1.33 (0.62) 0.06
e
23.13 (25.17) 14.79 (34.01) 7.41 (19.58) 0.01
e 30.69 (24.69) 36.23 (20.30) 31.18 (31.97) 0.66
e
NOTE:  Column percent totals may not sum to 100% due to rounding; Bolded p-values indicated statistical significance; T1-T3 = 1st tertile through 3rd tertile
IQR, interquartile range; SD, Standard Deviation.
a 
Quercetin-rich foods: summary measure of apples, grapes, onions, artichoke/fennel/celery, beans, apricots, plums, turnips, peppers, strawberries, tomatoes, and broccoli.
b




 Chi-square test. 
e
 Non-parametric Kruskal-Wallis test. 




Adenocarcinoma Squamous Cell Carcinoma
former
current
Smoking status (%) 
never
BMI, mean (SD)
Male, n (%) 
Table 1.  Selected characteristics by sex-specific tertile (T1-T3) of quercetin-rich food
a
 intake in EAGLE, separately for histologic subtypes
Subject characteristics 
f
 Total vegetables intake: summary measure of tomatoes, peppers, carrots, salad, peas, beans/chickpeas, mushrooms, broccoli, turnips, savoy, black cabbage, onions, cooked spinach/Swiss 
g 
Total fruits intake: summary measure of apples, pears, bananas, kiwis, oranges/grapefruits, mandarins/clementines, grapes, peaches/clingstones, apricots, plums, strawberries, melons, and fruit 
cocktails.
h
 Total meat intake: summary measure of cooked ham (prosciutto cotto), smoked ham (prosciutto crudo), cured ham (speck), salami, baloney (mortadella), wurstel, salted sliced beef, coppa, pancetta, 
and other types of processed meats.
   Lifetime alcohol
b
, median (IQR)
   Meats
b,h
, median (IQR)
   Fruits
b,g
, median (IQR)










T1 mean T3 mean Fold Change p-value
Adenocarcinoma (n=97)
hsa-miR-502 1.089 1.224 1.124 0.0169
hsa-mir-564 1.76 1.566 0.89 0.0297
hsa-miR-124a 1.261 1.074 0.852 0.0440
hsa-miR-125a 1.869 2.813 1.505 0.0450
Squamous Cell Carcinoma (n=78)
hsa-miR-510 1.327 1.158 0.872 0.0026
hsa-mir-605 8.312 3.591 0.432 0.0040
hsa-miR-155 0.006 0.008 1.399 0.0122
hsa-miR-373 0.995 0.913 0.917 0.0142
hsa-miR-453 1.817 1.635 0.899 0.0166
hsa-miR-502 1.374 1.1 0.801 0.0172
hsa-miR-18b 0.073 0.108 1.483 0.0197
hsa-miR-183 3.189 2.179 0.683 0.0215
hsa-mir-573 1.306 1.134 0.869 0.0243
hsa-miR-524 1.077 0.921 0.855 0.0358
hsa-mir-612 0.843 0.901 1.069 0.0420
hsa-miR-363 0.927 1.132 1.222 0.0464
Adjusted for age, sex, BMI, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat, alcohol, and 
cigarette packyears
Table 2. MiRs that significantly (at P <0.05) differentiate highest (T3) versus lowest (T1) 
consumers of quercetin-rich food intake, separately by histology  






miR name Fold Change P -value* miR name Fold Change P -value*
hsa-mir-641 0.8280 0.0029 hsa-mir-580 0.7670 0.0028
hsa-miR-29b 1.0920 0.0033 hsa-miR-215 0.7660 0.0039
hsa-miR-146a 0.8900 0.0058 hsa-miR-194 0.6480 0.0107
hsa-miR-500 0.8390 0.0077 hsa-mir-598 0.5740 0.0157
hsa-let-7e 1.2700 0.0175 hsa-miR-518a-2 0.9290 0.0197
hsa-miR-134 0.9520 0.0196 hsa-miR-503 0.6770 0.0369
hsa-miR-26b 2.0030 0.0214 hsa-miR-146b 1.4970 0.0430



















miR name Fold Change P -value* miR name Fold Change P -value*
hsa-miR-492 1.129 0.0115 hsa-miR-502 0.782 0.0103
hsa-miR-510 0.785 0.0212 hsa-mir-605 0.335 0.0127
hsa-miR-491 1.165 0.0227 hsa-miR-506 0.644 0.0166
hsa-mir-612 1.168 0.0252 hsa-miR-183 0.397 0.0282






*Coefficient P-value from ANOVA model adjusted for age, sex, BMI, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat, 
alcohol, and cigarette packyears.
Table 3: Influence of quercetin-rich food intake (T3-vs-T1) on individual miR, stratified by histology and smoking status
Former smokers (n=44) Current smokers (n=42)
Former smokers (n=38) Current smokers (n=40)





























Function Former Current Former Current 
P- value* P- value* P- value* P- value*










miR-146 family hsa-miR-146a P =0.002 P =0.092 P =0.753 P =0.222
Tumor growth and invasion hsa-miR-146b
miR-26 family hsa-miR-26a P =0.010 P =0.623 P =0.588 P =0.664
Apoptosis hsa-miR-26b






miR-29 family hsa-miR-29a P =0.064 P =0.373 P =0.886 P =0.137
DNA methylation hsa-miR-29b
hsa-miR-29c
miR-18 family hsa-miR-18a P =0.705 P =0.220 P =0.156 P =0.392
Tumor progression hsa-miR-18b
miR-34 family hsa-miR-34a P =0.142 P =0.649 P =0.275 P =0.568
Tumor suppressor hsa-miR-34c
miR-19 family hsa-miR-19a P =0.072 P =0.991 P =0.608 P =0.103
Tumor progression hsa-miR-19b





*p-value based on Functional Class Score as described in the Methods section
Models adjusted for age, sex, BMI, smoking status, non-quercetin-rich fruits and vegetables, red/processed meat, alcohol, and 
cigarette packyears.
a
Refer to Supplemental Table S5 for more detailed functions
Adenocarcinoma Squamous Cell Carcinomas
Table 4. Influence of quercetin-rich food intake (T3-vs-T1) on family of functional
a
 miR, stratified by 
histology and smoking status
miRNA members
NOTE:  Only results of miR families that had at least one miR that were significant at p-value <0.05 from individual-based miR 
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